Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Xiaobing,Yang ^[1] ; Jiahui,Zhao ^[1] ; Dechao,Wei ^[1] ; Tao,Feng ^[1] ; Pengju,Guo ^[1] ; Qiankun,Li ^[1] ; Yongxing,Wang ^[1] ; Yili,Han ^[1] ; Mingchuan,Li ^[1] ; Yongguang,Jiang ^[1] ; Yong,Luo ^[1]

作者单位： Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. ^[1]

关键词 Arsenic trioxide DNA damage repair Enzalutamide castration-resistant prostate cancer combination therapy drug resistance

主题词男(雄)性(Male);人类(Humans);受体, 雄激素(Receptors, Androgen);抗药性, 肿瘤(Drug Resistance, Neoplasm);细胞系, 肿瘤(Cell Line, Tumor);腈类(Nitriles);细胞增殖(Cell Proliferation)

DOI 10.1080/1120009X.2023.2194183

PMID 37011019

发布时间 2023-11-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of chemotherapy (Florence, Italy)

2023年35卷8期

760-770页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer.

Journal of chemotherapy (Florence, Italy)

相似文献

Journal of chemotherapy (Florence, Italy)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer.

Journal of chemotherapy (Florence, Italy)

相似文献

Journal of chemotherapy (Florence, Italy)

相关期刊

检索历史清除